So Many Data Slides, So Little Time

We see a lot of scientific data slides – data on animal studies, MOAs, clinical data and more. Alas, with so many data slides, the impact can get subsumed. Audiences are interested in the underlying science or clinical trials, but they’re also interested in the overarching story – what is the problem being solved, why is this an important problem, what expertise does the company bring? With these questions in mind, we offer the following tips for turning data deluge into descriptive data.

Animal Data: Animal data can be compelling, especially for certain indications where there are good animal models. That said, we suggest no more than two showing the data itself, then move on to putting the science in context – the problem being solved and the advantage your company brings.

Mechanism of Action: Our best advice for MOA?  Consider using simple graphics or an animation. Use the fewest data slides you can. Don’t try to tell the audience everything you want them to know. Rather, what is it they cannot forget. Any additional data can go in an optional appendix.

Disease Data: There are two types of disease data: data that defines the scope of the problem being solved, and data that helps explain the nature of the disease being studied. When considering which slides to include in a presentation, first take into account the message to be conveyed – do you need a data slide to define the scope? Maybe an at-a-glance number will do. As to the disease itself, this may best be conveyed with pictures.

Clinical Trials: Clinical trial data is of great interest. The challenge is deciding how much data to present and in which format.  In terms of how much data, we recommend tailoring to the audience. Obviously, if you’re meeting with the head of clinical development from large pharma who is contemplating partnership, more data will be required. But, for other audiences, tailor to their needs. In terms of format, beware the tendency to use too-small, indecipherable graphs. As noted above, focus on what it is that the audience must remember. What do you want to ensure they take away from the clinical trial output.

Data slides are important, but not at the expense of losing the audience in an abundance of scientific statistics. The strategy, mission, plan and people are also important inputs.If you focus on the big picture and ensure data slides are an important element, rather than the reigning role, your company story will be more memorable.

LaVoieHealthScience provides strategic communications, investor relations and public relations to build recognition, increase sales and value for health science innovations. Contact us at info@lavoiehealthscience.com to learn more.